What Is the Normal Range of Calprotectin by Age?

Fecal calprotectin levels vary dramatically with age, and no single number works as a universal cutoff for “normal.” Healthy newborns routinely produce levels that would alarm a gastroenterologist if they showed up in an adult’s chart. In general terms, infants in their first few months of life can have median values above 300 µg/g, children over age four settle closer to adult territory, and healthy adults under 50 tend to fall below about 50 µg/g. After age 70, levels climb again even without disease. Understanding where your age group fits on this curve matters, because a result that looks worrying at one stage of life can be perfectly normal at another.

What Calprotectin Actually Measures

Calprotectin is a protein found mainly inside neutrophils, a type of white blood cell that rushes to sites of inflammation. When the lining of your gut is inflamed, neutrophils migrate into the intestinal wall and get shed into the stool, bringing calprotectin with them. A fecal calprotectin test measures how much of this protein ends up in a stool sample, giving doctors an indirect readout of how much inflammation is happening in the intestines.¹ The beauty of the test is that it’s non-invasive and relatively cheap compared to a colonoscopy, which is why it has become a go-to screening tool when a doctor is trying to decide whether gut symptoms warrant further investigation.

Infants and the Strikingly High Baseline

If you’re a parent who received a calprotectin result for your baby and panicked at a number in the hundreds, you’re not alone, but in most cases the result is completely normal for a young infant. A study of fecal calprotectin in children found median values of about 375 µg/g in babies aged one to three months and roughly 218 µg/g in those aged three to six months. After six months, levels dropped to around 100 µg/g and continued declining through 18 months.² Other research confirms the same pattern: calprotectin in infants under six months runs well above what would be considered the upper limit of normal in older children or adults, then gradually falls.³

Why are infant levels so high? The prevailing explanation centers on the developing gut. A newborn’s intestinal lining is immature, more permeable, and undergoing rapid immune system education. Neutrophils are active participants in that process, so calprotectin naturally floods the stool. Research also suggests that delivery method plays a role: babies born vaginally tend to have higher calprotectin than those born by cesarean section, likely because of differences in early microbial colonization of the gut.⁴

Breastfed Versus Formula-Fed Babies

Feeding method creates another layer of variation that catches many parents off guard. In one study comparing exclusively breastfed and formula-fed infants, breastfed babies had a median fecal calprotectin of 555 µg/g, while formula-fed babies averaged about 207 µg/g. That’s a nearly threefold difference, and it was statistically significant even after accounting for how often each group pooped.⁵ The researchers speculated that growth factors, hormones, and immune-stimulating compounds in human milk actively drive the development of the infant’s gut immune system, producing more neutrophil traffic as a byproduct. The practical takeaway is that a breastfed baby with a calprotectin reading of 500 or even 600 µg/g can be entirely healthy. Using a standard adult cutoff of 50 µg/g to interpret that result would be wildly misleading.

The Childhood Decline

Calprotectin levels keep falling throughout early childhood in a pattern that’s fairly predictable. A large study of over 11,000 children found that infants under one year had a median level of 51 mg/kg (with a 95th percentile reaching a striking 648 mg/kg), while children aged one to ten had median values roughly three to four times lower. By the time children hit the 11-to-18 age bracket, median values had dropped to somewhere between 11 and 19 mg/kg across yearly age groups.⁶ A cross-sectional study of healthy Hungarian infants confirmed this trajectory, showing a pronounced decline that follows a roughly quadratic curve: highest in the first four months, progressively lower from four to twelve months, and lower still from twelve to thirty-six months.⁷

What this means in practice is that pediatric gastroenterologists need age-specific reference ranges, not a one-size-fits-all cutoff. A level of 150 µg/g in a three-month-old is unremarkable; the same number in a ten-year-old warrants a closer look.

Adult Reference Ranges and the Over-70 Climb

For healthy adults under 50, calprotectin concentrations tend to stay comfortably low. One study of healthy Korean adults reported an average of about 16 µg/g in those under 50. Between ages 50 and 69, the average rose to roughly 35 µg/g. And above age 70, the average jumped to about 160 µg/g, with individual values ranging from under 1 to over 545 µg/g.⁸ That tenfold increase between middle age and old age is important because the standard clinical cutoff many labs use is 50 µg/g, sometimes with a “grey zone” of 50–200 µg/g. A healthy 75-year-old could easily cross that cutoff without any bowel disease at all. Broader evidence puts the normal adult range at roughly 10 to 50 µg/g, though results vary depending on the study population and which test kit is used.⁴

The reason for higher levels in older adults isn’t entirely settled, but the leading hypothesis involves low-grade chronic inflammation that accumulates with aging, sometimes called “inflammaging.” Changes in gut microbiome composition, increased intestinal permeability, and higher rates of medication use (more on that below) all contribute. The upshot is that some clinicians argue for age-adjusted cutoffs in older patients to avoid unnecessary colonoscopies, though no universally agreed-upon set of age-stratified thresholds has been adopted across guidelines.

Preterm Infants Are a Special Case

Premature babies add another wrinkle. Their calprotectin levels show gestational-age-dependent patterns, with extremely premature infants (born before 26 weeks) sometimes having paradoxically low readings because their immature gut produces fewer neutrophils. One study of over 200 premature infants found that gestational and postnatal age both affected calprotectin dynamics, and that extremely premature babies needed their own reference values rather than the already-elevated infant norms.⁹

Calprotectin testing in this population is particularly important for detecting necrotizing enterocolitis (NEC), a serious and sometimes fatal bowel condition that primarily strikes preterm infants. A meta-analysis found that fecal calprotectin had pooled sensitivity around 91% and specificity around 93% for NEC in preterm babies.¹⁰ However, there’s a counterintuitive finding: in cases of fulminant NEC, where the bowel wall is severely damaged, calprotectin levels can actually drop to unusually low values because the tissue is too destroyed to produce the inflammatory response. In the premature infant study, a calprotectin level below 24 µg/g was a red flag for this devastating form of the disease.⁹ That’s an unsettling situation where a “normal-looking” low value is actually dangerous.

How the Test Helps Distinguish IBD From IBS

The most common clinical use of fecal calprotectin in adults and older children is as a screening tool to figure out whether gut symptoms like abdominal pain, diarrhea, and bloating are caused by inflammatory bowel disease (IBD, which includes Crohn’s disease and ulcerative colitis) or by irritable bowel syndrome (IBS), which involves no measurable inflammation. The distinction matters because IBD usually requires colonoscopy, imaging, and often lifelong medication, while IBS is managed differently.

A meta-analysis of studies using a cutoff of 50 µg/g found that calprotectin correctly identified IBD with a pooled sensitivity of about 93% and specificity of about 94% in adults.¹¹ A more recent meta-analysis reported slightly different numbers, with sensitivity around 86% and specificity about 92%.¹² Either way, a low calprotectin result in someone with chronic gut symptoms makes IBD much less likely, often allowing doctors to avoid colonoscopy. The test is better at ruling IBD out than ruling it in; a high result still needs confirmation with endoscopy because other conditions can elevate levels too.¹

Medications That Can Inflate Your Result

One of the most underappreciated causes of a falsely elevated calprotectin result is medication. Non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, naproxen, and diclofenac can cause low-level intestinal inflammation even when your stomach feels fine. In a controlled study where healthy volunteers took diclofenac for two weeks (with a stomach-protecting drug on board), three-quarters of them ended up with calprotectin levels above the upper limit of normal.¹³ This is not a harmless lab artifact: NSAIDs genuinely irritate the small bowel lining, and the calprotectin test is doing its job by detecting that irritation. The problem arises when the result is interpreted as evidence of IBD rather than a drug side effect.

Proton pump inhibitors (PPIs) like omeprazole and pantoprazole also seem to be associated with higher readings. A study of patients with functional bowel disorders found that those taking PPIs had a median calprotectin of 66 µg/g compared to 23 µg/g in those who were not, while NSAID users had a median of 57 µg/g versus 25 µg/g in non-users.¹⁴ If you’ve been asked to do a calprotectin test, it’s worth asking your doctor whether any of your current medications could influence the result. Some clinicians recommend stopping NSAIDs for at least two weeks before testing if safely possible, though this isn’t always practical.

Rheumatoid Arthritis and Other Non-Gut Conditions

Calprotectin is primarily a gut inflammation marker, but systemic inflammatory conditions can push levels up even when the intestines themselves are fine. A study of patients with newly diagnosed rheumatoid arthritis found a mean fecal calprotectin of 71 µg/g at diagnosis, compared to 17 µg/g in healthy controls. Over a third of the RA patients had levels above 50 µg/g, versus only 4% of controls. After adjusting for NSAID use, age, and sex, having new-onset RA itself remained a significant predictor of elevated fecal calprotectin.¹⁵ This makes sense given that calprotectin circulates in the blood during systemic inflammation and could end up in stool through mucosal leakage. Infectious gastroenteritis, celiac disease, and cystic fibrosis can also elevate levels.¹

Not All Calprotectin Tests Give the Same Number

Here’s something that complicates interpretation in the real world: different calprotectin assays can return meaningfully different numbers from the same stool sample. Although various tests correlate with each other, the actual values they produce can diverge. One comparison study found that while three different assays correlated significantly with one another, the slopes and intercepts of their pairwise comparisons differed, meaning a result of 100 µg/g on one test might correspond to a substantially different number on another.¹⁶

Home-use rapid tests, which are increasingly popular for IBD patients monitoring their own disease, add more variability. In a head-to-head comparison, three home calprotectin tests showed reasonable agreement with their companion lab assays at low concentrations (76% to 87% agreement below 500 µg/g), but agreement fell to just 19% to 37% at higher concentrations.¹⁷ That’s troublesome for patients with active IBD who are relying on home tests to track flares: the high-range readings they care most about are exactly where the tests are least reliable. The practical implication is that you should interpret trends over time using the same test, not compare raw numbers across different brands or platforms.

How Much Your Result Can Bounce Around Day to Day

Even if you use the same test on the same person, calprotectin levels can vary quite a bit from one sample to the next. One study in patients without colonic inflammation found that the average calprotectin was 70 µg/g, but individual readings from the same people over multiple days ranged from 9 to 461 µg/g, with a within-person standard deviation of 52 µg/g.¹⁸ Another study of IBD patients found that calprotectin variability was not systematically tied to the time of day or to specific days of the week.¹⁹

In patients with active ulcerative colitis, within-day fluctuation can be extreme: one study reported a median coefficient of variation of 40% across multiple samples taken the same day, with some patients seeing swings from low to high ranges by thousands of µg/g. The first stool of the morning was neither consistently the highest nor the lowest sample of the day.²⁰ This level of biological noise means that a single borderline reading should never be over-interpreted. Doctors who work with calprotectin regularly understand this and often order repeat tests or track the trend over multiple samples before making clinical decisions.

Getting the Sample to the Lab Without Losing Accuracy

How you handle the stool sample between collection and analysis matters more than most patients realize. Calprotectin breaks down over time, especially at room temperature. One multi-assay study found that after four days of storage at room temperature, calprotectin concentrations in untreated stool dropped by 30% to 60% compared to baseline, depending on the assay. Refrigerated samples at 4°C remained stable for about eight days.²¹ A pediatric study confirmed the trend, showing an average decline of about 35% after six days at room temperature, with significantly better stability in refrigerated samples.²²

Some extraction buffers help preserve calprotectin in the sample. One study showed that a commercial extraction buffer maintained stability at room temperature for up to four days with a very strong correlation to fresh results.²³ If your doctor gives you a collection kit with an extraction device, use it at the time of collection rather than scooping stool into a plain container. And if you can’t get the sample to the lab the same day, pop it in the fridge. A falsely low result from degraded calprotectin could lead to missed inflammation, which in children with IBD could mean under-treatment.²²

Obesity and Fecal Calprotectin

Given the well-known links between obesity and chronic low-grade inflammation, you might expect obese individuals to have higher fecal calprotectin. The evidence on this is surprisingly thin. A study comparing obese and normal-weight adults and children found no statistically significant difference in fecal calprotectin between obese and non-obese people within the same age group. Adult levels ranged from median values of about 10 µg/g in obese adults to 9.5 µg/g in normal-weight adults, which is essentially identical. The pediatric results were similarly overlapping.²⁴ This suggests that while obesity drives systemic inflammation, the gut-specific signal that calprotectin measures doesn’t seem to track with body weight alone. It’s a useful reminder that calprotectin is a gut-focused marker, not a general inflammation thermometer.

1
PubMed Central. Faecal Calprotectin
2
PubMed Central. Fecal Calprotectin Concentrations in Children
3
PubMed. Delivery and feeding mode affects fecal calprotectin levels in infants <7months old
4
PubMed Central. Calprotectin: from biomarker to biological function – Section: Faecal CP in health and disease
5
PubMed. High faecal calprotectin levels in healthy, exclusively breast-fed infants
6
PubMed. Concentration of fecal calprotectin in 11,255 children aged 0-18 years
7
BMJ Open. Faecal calprotectin reference ranges in early childhood: a cross-sectional study of healthy infants in Hungary
8
Korean Journal of Clinical Laboratory Science. Age-Related Fecal Calprotectin Concentrations in Healthy Adults
9
PubMed. Fecal calprotectin concentrations in premature infants have a lower limit and show postnatal and gestational age dependence
10
PubMed. Diagnostic value of fecal calprotectin in necrotizing enterocolitis: A meta-analysis
11
PubMed Central. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation
12
PubMed. Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults
13
Gastroenterology. A Quantitative Analysis of NSAID-Induced Small Bowel Pathology by Capsule Enteroscopy
14
PubMed. Prescription of NSAIDs and proton pump inhibitors are associated with increased faecal calprotectin levels in patients with functional bowel disorder: an observational study
15
Arthritis & Rheumatology. Increased Levels of F-calprotectin in Patients with Early Rheumatoid Arthritis at Diagnosis
16
Intestinal Research. Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease
17
PubMed Central. Head-to-head comparison of three stool calprotectin tests for home use
18
PubMed. Biological variability of fecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm
19
PubMed. Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure
20
PubMed. High within-day variability of fecal calprotectin levels in patients with active ulcerative colitis: what is the best timing for stool sampling?
21
The Journal of Applied Laboratory Medicine. Impact of Preanalytical Factors on Calprotectin Concentration in Stool: A Multiassay Comparison
22
PubMed Central. Calprotectin instability may lead to undertreatment in children with IBD
23
PubMed Central. Fecal Calprotectin: A Comparison of Two Commercial Enzymoimmunoassays and Study of Fecal Extract Stability at Room Temperature
24
PubMed Central. A Study of Fecal Calprotectin in Obese Children and Adults